Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

SeqWright invests in LaserGenís novel reversible terminator chemistry
May 2009
SHARING OPTIONS:

HOUSTONóSeqWright Inc., a commercial provider of genomic analysis and molecular biology services, will make an undisclosed equity investment in LaserGen Inc., a DNA sequencing technology company, the parties announced in April.
 
The decision followed LaserGen's recently revealed plans to commercialize its novel reversible terminator chemistry, Lightning Terminators, for next-generation sequencing applications.
 
SeqWright's investment and next-generation sequencing expertise are expected to facilitate LaserGen's goal of bringing its chemistry as reagent kits to the market as early as 2010 by forming strategic partnerships with existing next-generation instrument manufacturers. Financial terms of the transaction were not disclosed.
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.